Please login to the form below
Foundation Medicines
This page shows the latest Foundation Medicines news and features for those working in and with pharma, biotech and healthcare.
US start-up EQRx promises approach that will slash drug prices
in 2018 – and Blueprint Medicines which has just claimed its first approval for a high-priced cancer drug. ... Other key figures in EQRx include former Foundation Medicine and McKesson executive Melanie Nallicheri, who serves as president and chief
Latest news
-
AstraZeneca to develop Lynparza companion diagnostic
To do so AZ has joined forces with molecular information firm Foundation Medicines, whose FoundationOne genomic profiling platform will be used to develop the test. ... Nina Mojas, global medicine lead for Lynparza at AstraZeneca, said: “Utilising
-
The distance travelled
When medicines were approved, the community thought that prices were too high and wanted a greater say in the development and delivery of medicines. ... Unimaginable thirty years ago, most companies now collaborate with not-for-profit organisations like
AstraZeneca to develop Lynparza companion diagnostic
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Interview: Harvey Berger and Timothy Clackson, Ariad
treatments.”. It's the results of strategy to “discover, develop and deliver our medicines without the additional input of pharma partners”, says Berger. ... We are building a strong commercial presence, but it is one that is built on what
Interview: Harvey Berger and Timothy Clackson, Ariad
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
-
Digital strategist
-
Competitive
-
Events Executive
-
Depending on Experience
-
Digital project manager
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- AZ’s PNH therapy Ultomiris wins EU backing to expand use for children
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Straight outta lockdown – what’s next for flexible working?
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Assessing the value of interim analyses in clinical trials
- Patient diversity in clinical trials needs to be centre stage
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
